Roy Beveridge, MD, Discusses Pathways, NCCN Guidelines in EGFR Exon 20 Insertion+ NSCLC
Beveridge, now with Avalere Health, addressed the importance of clinical pathways in selecting therapies in non-small cell lung cancer (NSCLC) and the emergence of options for EGFR Exon 20 Insertion+ NCSLC.
What We’re Reading: FDA Approves ALS Drug; Role of Microbes in Tumors; Suicides Increased in 2021
The FDA approved AMX0035 (Relyvrio) for amyotrophic lateral sclerosis (ALS) Thursday; new research suggests looking at microbes and fungi within cancer tumors; US suicides increased in 2021 following a 2-year decrease in deaths by suicide.
Dr Vamshi Rao Discusses Early Intervention and Treatment Choices in SMA
Early intervention for spinal muscular atrophy (SMA) is crucial to reduce disability due to the disease, said Vamshi Rao, MD, attending physician, Children’s Hospital of Chicago; assistant professor, Northwestern University Feinberg School of Medicine.
What We’re Reading: Teen Substance Use Trends; Physician Burnout Increasing; Employee Mental Health
Alcohol and cigarette use among teens declined between 1991 and 2019, while vape use increased; most US physicians reported at least 1 symptom of burnout between the end of 2021 and beginning of 2022; an estimated 12 billion annual workdays are lost due to depression and anxiety among employees.
Dr David Rosmarin Discusses the Economic Burden on Patients With Vitiligo
Coverage of vitiligo treatments is variable and patients can face an economic burden in the form of direct and indirect costs, explained David Rosmarin, MD, vice chair, education and research at Tufts Medical Center.
What We’re Reading: Hospitals’ Pursuit of Profits; Opioid Crisis Funding; Arizona Abortion Ban
Nonprofit hospitals pursue profits from low-income patients; the Biden administration announced that $1.5 billion would be set aside to battle opioid overdoses and support recovery; an Arizona judge ruled that a state law that criminalizes nearly all abortions could take effect immediately.